Pharmaceutical Medicine, Biotechnology and European Law
Pharmaceutical Medicine, Biotechnology and European Law
$130.00
USDEuropean law has been faced with increasingly complex issues emerging from rapid developments in pharmaceutical medicine and biotechnology. A team of distinguished European legal practitioners and academics reassess the impact of European law on health care and pharmaceutical law. The essays are grouped under four themes: Free movement of goods and persons, competition and intellectual property; European drug regulation; Biotechnology; and Product liability and transnational health care litigation. The book reviews the impact of European law on movement of health care professionals and pharmaceuticals, patent and trademark rights, the Product Liability Directive, laws on product liability and intellectual property claims. It examines recent developments in drug regulation, particularly data protection, abridged applications for marketing authorisations and the European Medicines Evaluation Agency. A compelling analysis is made of the Biotechnology Directive morality clauses. This important study offers a valuable resource for the pharmaceutical and biotechnology industries, legal academics and practitioners alike.
- Unique contribution to the literature in the pharmaceutical and health care law area
- Of vital interest to the medical and legal representatives of the pharmaceutical and biotechnology industries, as well as legal academics and practitioners
- Discussion of industries of global importance
Reviews & endorsements
"...the collection of essays in Pharmaceutical Medicine vividly portrays the tensions and sheer ambition and complexities of superimposing European-wide bodies and law on national markets and member states to create a European market in pharmeceutical medicine and biotechnology...a welcome contribution." Journal of Legal Medicine
Product details
February 2001Hardback
9780521792493
280 pages
236 × 159 × 26 mm
0.578kg
Available
.jpg)
Table of Contents
- Notes on the contributors
- Preface
- Introduction Richard Goldberg and Julian Lonbay
- Part I. Free Movement of Goods and Persons, Competition and Intellectual Property:
- 1. The free movement of goods I: pharmaceuticals, patents and parallel trade Professor W. R. Cornish
- 2. The free movement of goods II: pharmaceuticals, trade marks and parallel imports Belinda Isaac
- 3. The free movement of health care professionals in the European Community Julian Lonbay
- 4. EC competition law, drugs and intellectual property: recent developments Professor Leigh Hancher
- Part II. European Drug Regulation:
- 5. Data protection and abridged applications for marketing authorisations in the pharmaceutical industry Ian Dodds-Smith
- 6. The role of the European Medicines Evaluation Agency (EMEA) in the harmonisation of pharmaceutical regulation Antoine Cuvillier
- Part III. Biotechnology:
- 7. The morality clauses of the Directive on the Legal Protection of Biotechnological Inventions: conflict, compromise, and the patent community Deryck Beyleveld, Professor Roger Brownsword and Margaret Llewelyn
- Part IV. Product Liability and Transnational Health Care Litigation:
- 8. The development risk defence and the European Court of Justice
- increased injury costs and the Supplementary Protection Certificate Richard Goldberg
- 9. Transnational health care litigation and the Private International Law (Miscellaneous Provisions) Act 1995, Part III Jonathan Harris
- Index.
